The Valley Desk

ArticleClinical genitourinary cancerPublished

Clinical Outcomes of Metastatic Urothelial Carcinoma Patients Discontinuing Enfortumab Vedotin Due to Toxicity and/or Clinical Response

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Lewis Katz School of Medicine, Temple University, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Clinical genitourinary cancer
Published
Subject terms
Humans; Carcinoma, Transitional Cell; Urologic Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Treatment Outcome; Retrospective Studies; Aged; Aged, 80 and over; Middle Aged; Female; Male
PubMed ID
42618453
Added to directory
Source checked

Report a correction or request removal